← Leaderboards
Maciej Michal Markiewski
Texas Tech University Health Scis Center
$1,739,439
Attributed
$1,739,439
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $350K · FY2016–20$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,739,439 · 1
By mechanism
R01$1,739,439 · 1
Top collaborators
No co-investigators on record.
Most similar at Texas Tech University Health Scis Center
Same institution · by research overlap
- Laurence Michael Wood$376,776
Others in their field
Top investigators on “Density”
- Maury Tigner · Cornell University$99,355,712
- Daniel R Marlow · University Of California-Los Angeles$64,882,770
- Richard A Gibbs · Baylor College Of Medicine$49,140,324
- Steven R Cummings · University Of California San Francisco$44,409,636
- Thierry Diagana · University Of Texas Med Br Galveston$37,506,320
- Vineet D Menachery · Univ Of North Carolina Chapel Hill$37,506,320
Research focus
DensityFailureAffectBaseAdverse EffectsDesignAngiogenesis InhibitorsBreast Cancer ModelBreast CarcinomaC5a Anaphylatoxin ReceptorCancer EtiologyBiologyCancer ModelAngiogenesisBlood VesselsCessation Of LifeChemotherapy-Oncologic ProcedureClinicClinically RelevantComparative EfficacyComplementComplement 5aComplement ActivationFda Approved
Grant awards (5)
Targeting the Premetastatic Niche by Antiangiogenic Immunotherapy$349,988
R01 · FY2020 · CA · contact PI
Targeting the Premetastatic Niche by Antiangiogenic Immunotherapy$339,487
R01 · FY2019 · CA · contact PI
Targeting the Premetastatic Niche by Antiangiogenic Immunotherapy$349,988
R01 · FY2018 · CA · contact PI
Targeting the Premetastatic Niche by Antiangiogenic Immunotherapy$349,988
R01 · FY2017 · CA · contact PI
Targeting the Premetastatic Niche by Antiangiogenic Immunotherapy$349,988
R01 · FY2016 · CA · contact PI